实用临床医药杂志
實用臨床醫藥雜誌
실용림상의약잡지
JOURNAL OF JIANGSU CLINICAL MEDICINE
2014年
17期
56-58,62
,共4页
丛智荣%刘红%徐小红%江棋%沈茜%曹永峰%倪静怡
叢智榮%劉紅%徐小紅%江棋%瀋茜%曹永峰%倪靜怡
총지영%류홍%서소홍%강기%침천%조영봉%예정이
Ki-67%弥漫大B细胞淋巴瘤%预后
Ki-67%瀰漫大B細胞淋巴瘤%預後
Ki-67%미만대B세포림파류%예후
Ki-67%diffuse large B cell lymphoma%prognosis
目的:通过观察Ki-67在弥漫大B细胞淋巴瘤(DLBCL)与淋巴结反应性增生中以及在生发中心B细胞(GCB)型和非GCB型(non-GCB)中的表达差异,探讨Ki-67的临床意义。方法将60例DLBCL标本设为观察组,将20例淋巴结反应性增生组织标本设为对照组。比较Ki-67在GCB型和non-GCB型中的表达差异,并分析Ki-67与DLBCL分型、国际预后指数(IPI)、近期疗效、预后的关系。结果 Ki-67在观察组和对照组的平均表达率分别为(69.17±14.73)%和(40.50±14.95)%,差异有统计学意义(t=7.509,P<0.0001)。Ki-67在GCB型和non-GCB中的平均表达率分别为(59.29±14.92)%和(71.96±13.39)%,有显著差异(t=3.019,P=0.0038)。Ki-67在IPI<2组和IPI≥2组中的平均表达率分别为(65.29±15.17)%和(74.23±12.70)%,差别有统计学意义(t=2.422,P=0.0186)。结论 Ki-67的异常表达与DLBCL的临床分期、IPI指数、分型、近期疗效及预后等相关,对判断疗效和预后具有重要临床价值。
目的:通過觀察Ki-67在瀰漫大B細胞淋巴瘤(DLBCL)與淋巴結反應性增生中以及在生髮中心B細胞(GCB)型和非GCB型(non-GCB)中的錶達差異,探討Ki-67的臨床意義。方法將60例DLBCL標本設為觀察組,將20例淋巴結反應性增生組織標本設為對照組。比較Ki-67在GCB型和non-GCB型中的錶達差異,併分析Ki-67與DLBCL分型、國際預後指數(IPI)、近期療效、預後的關繫。結果 Ki-67在觀察組和對照組的平均錶達率分彆為(69.17±14.73)%和(40.50±14.95)%,差異有統計學意義(t=7.509,P<0.0001)。Ki-67在GCB型和non-GCB中的平均錶達率分彆為(59.29±14.92)%和(71.96±13.39)%,有顯著差異(t=3.019,P=0.0038)。Ki-67在IPI<2組和IPI≥2組中的平均錶達率分彆為(65.29±15.17)%和(74.23±12.70)%,差彆有統計學意義(t=2.422,P=0.0186)。結論 Ki-67的異常錶達與DLBCL的臨床分期、IPI指數、分型、近期療效及預後等相關,對判斷療效和預後具有重要臨床價值。
목적:통과관찰Ki-67재미만대B세포림파류(DLBCL)여림파결반응성증생중이급재생발중심B세포(GCB)형화비GCB형(non-GCB)중적표체차이,탐토Ki-67적림상의의。방법장60례DLBCL표본설위관찰조,장20례림파결반응성증생조직표본설위대조조。비교Ki-67재GCB형화non-GCB형중적표체차이,병분석Ki-67여DLBCL분형、국제예후지수(IPI)、근기료효、예후적관계。결과 Ki-67재관찰조화대조조적평균표체솔분별위(69.17±14.73)%화(40.50±14.95)%,차이유통계학의의(t=7.509,P<0.0001)。Ki-67재GCB형화non-GCB중적평균표체솔분별위(59.29±14.92)%화(71.96±13.39)%,유현저차이(t=3.019,P=0.0038)。Ki-67재IPI<2조화IPI≥2조중적평균표체솔분별위(65.29±15.17)%화(74.23±12.70)%,차별유통계학의의(t=2.422,P=0.0186)。결론 Ki-67적이상표체여DLBCL적림상분기、IPI지수、분형、근기료효급예후등상관,대판단료효화예후구유중요림상개치。
Objective To investigate the different expressions of Ki-67 between diffuse large B cell lymphoma (DLBCL)and the reactive hyperplasia of lymphnode (RH),germinal center B cells (GCB)and non-GCB types,and to explore the clinical significance of Ki-67.Methods Samples from 60 DLBCL patients served as observation group,while the other 20 tissue samples from patients with lymphoid reactive hyperplasia as control group.The difference of Ki-67 expres-sions between GCB and non-GCB were compared and the relationships between Ki-67 expression and DLBCL,the international prognostic index (IPI),short-term efficacy and prognosis were analyzed. Results The average expression rate of Ki-67 was (69.17±14.73)%and (40.50±14.95)% in observation and control groups respectively ,and the difference was significant (t= 7 .5 0 9 ,P<0.0001),and it was (59.29±14.92)%and (71.96±13.39)%in GCB and non-GCB groups (t= 3.019,P= 0.0038)and (65.29±15.17)% and (74.23±12.70)% in IPI<2 and IPI≥2 groups (t= 2.422,P= 0.0186),respectively.Conclusion The abnormal expression of Ki-67 is closely associated with clinical stages,index of IPI,types,short-term effect and prognosis in DLB-CL,which plays an important role in the diagnosis,treatment and prognosis of DLBCL.